US Stock MarketDetailed Quotes
ELAN Elanco Animal Health
- 13.425
- +0.025+0.19%
Trading Nov 22 14:23 ET
6.64BMarket Cap32.74P/E (TTM)
13.460High13.160Low2.07MVolume13.430Open13.400Pre Close27.54MTurnover0.42%Turnover RatioLossP/E (Static)494.35MShares18.80052wk High1.02P/B6.60BFloat Cap11.40052wk Low--Dividend TTM491.80MShs Float37.610Historical High--Div YieldTTM2.24%Amplitude7.880Historical Low13.336Avg Price1Lot Size
Elanco Animal Health Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -18.18%162M | 227.87%200M | 101.38%2M | -40.04%271M | 1,107.69%157M | 4.76%198M | -80.45%61M | -133.87%-145M | -6.42%452M | -94.17%13M |
| Net income from continuing operations | 133.21%364M | 48.45%-50M | -68.93%32M | -1,478.21%-1.23B | -161.11%-141M | -1,586.15%-1.1B | -870.00%-97M | 101.96%103M | 83.85%-78M | 50.00%-54M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --20M | ---- |
| Depreciation and amortization | -1.73%170M | -8.47%162M | -4.05%166M | 1.76%694M | 1.79%171M | 3.59%173M | 3.51%177M | -1.70%173M | -4.75%682M | -3.45%168M |
| Deferred tax | ---- | ---- | ---- | -40.35%-80M | ---- | ---- | ---- | ---- | 61.49%-57M | ---- |
| Other non cash items | -127.03%-10M | -250.00%-9M | -600.00%-30M | -67.15%68M | 1,050.00%19M | -50.67%37M | -95.04%6M | -53.85%6M | 176.00%207M | -150.00%-2M |
| Change In working capital | 818.52%248M | 164.71%22M | 59.68%-177M | 35.06%-300M | 289.61%146M | 2,800.00%27M | 34.62%-34M | -32.23%-439M | -425.00%-462M | -149.68%-77M |
| -Change in receivables | ---- | ---- | ---- | -385.71%-40M | ---- | ---- | ---- | ---- | 140.00%14M | ---- |
| -Change in inventory | ---- | ---- | ---- | 40.52%-160M | ---- | ---- | ---- | ---- | -1,027.59%-269M | ---- |
| -Change in payables and accrued expense | ---- | ---- | ---- | 4.08%-94M | ---- | ---- | ---- | ---- | 15.52%-98M | ---- |
| -Change in other current assets | ---- | ---- | ---- | 94.50%-6M | ---- | ---- | ---- | ---- | -536.00%-109M | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -18.18%162M | 227.87%200M | 101.38%2M | -40.04%271M | 1,107.69%157M | 4.76%198M | -80.45%61M | -133.87%-145M | -6.42%452M | -94.17%13M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 3,555.56%1.24B | 23.26%-33M | 167.27%37M | 5.59%-169M | 53.95%-35M | 2.70%-36M | -16.22%-43M | -89.66%-55M | 66.23%-179M | -2.70%-76M |
| Net PPE purchase and sale | -27.27%-42M | 19.05%-34M | 0.00%-24M | 18.13%-140M | 46.75%-41M | 8.33%-33M | -7.69%-42M | -26.32%-24M | -7.55%-171M | 22.22%-77M |
| Net intangibles purchase and sale | ---8M | --0 | --0 | -7.69%-14M | --0 | --0 | --0 | -100.00%-14M | 65.79%-13M | -125.00%-2M |
| Net business purchase and sale | 43,233.33%1.29B | --0 | 481.25%61M | ---19M | --0 | ---3M | --0 | ---16M | --0 | --0 |
| Net other investing changes | --0 | ---- | ---- | -20.00%4M | 100.00%6M | --0 | 75.00%-1M | 66.67%-1M | -44.44%5M | -82.35%3M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 3,555.56%1.24B | 23.26%-33M | 167.27%37M | 5.59%-169M | 53.95%-35M | 2.70%-36M | -16.22%-43M | -89.66%-55M | 66.23%-179M | -2.70%-76M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -753.50%-1.34B | -338.46%-93M | -115.52%-27M | 84.88%-83M | -65.48%-139M | 7.65%-157M | 141.05%39M | 187.00%174M | -361.43%-549M | -290.91%-84M |
| Net issuance payments of debt | -753.85%-1.33B | -348.65%-92M | -107.18%-13M | 84.66%-77M | -98.57%-139M | -1.30%-156M | 141.57%37M | 195.77%181M | -383.62%-502M | -288.89%-70M |
| Net other financing activities | -700.00%-8M | -150.00%-1M | -100.00%-14M | 87.23%-6M | --0 | 93.33%-1M | 128.57%2M | 36.36%-7M | -242.42%-47M | -122.58%-14M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -753.50%-1.34B | -338.46%-93M | -115.52%-27M | 84.88%-83M | -65.48%-139M | 7.10%-157M | 140.63%39M | 187.00%174M | -361.43%-549M | -290.91%-84M |
| Net cash flow | ||||||||||
| Beginning cash position | 13.35%416M | 8.49%345M | 2.03%352M | -45.92%345M | -19.78%369M | -27.61%367M | -7.02%318M | -45.92%345M | 26.09%638M | 1.55%460M |
| Current changes in cash | 1,220.00%66M | 29.82%74M | 146.15%12M | 106.88%19M | 88.44%-17M | 129.41%5M | -68.16%57M | 91.07%-26M | -269.33%-276M | -176.17%-147M |
| Effect of exchange rate changes | 366.67%8M | 62.50%-3M | -1,800.00%-19M | 29.41%-12M | --0 | 90.00%-3M | 42.86%-8M | 80.00%-1M | 45.16%-17M | 500.00%32M |
| End cash Position | 32.79%490M | 13.35%416M | 8.49%345M | 2.03%352M | 2.03%352M | -19.78%369M | -27.61%367M | -7.02%318M | -45.92%345M | -45.92%345M |
| Free cash flow | -32.12%112M | 773.68%166M | 87.98%-22M | -56.34%117M | 275.76%116M | 15.38%165M | -93.19%19M | -107.95%-183M | -6.29%268M | -150.00%-66M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data